Stocks/FOLD

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

FOLD

↓ PDF (Pro)
Amicus Therapeutics Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$14.49
+0.00%today
MKT CAP
$4.5B
+0.2% · 1Y
Earnings History
-62.9%
-41.8%
+36.7%
-44.8%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$14.49
Low
$14.50
Analyst Mean
$14.50
High
$14.50
5 analystsHold
Full Financials
Trailing P/E-
Forward P/E15.1x
EV/EBITDA112.0x
Price/Sales-
Dividend Yield-
Revenue Growth YoY+23.7%
Earnings Growth YoY-95.5%
Revenue Growth QoQ+9.6%
5y Revenue CAGR+24.4%
5y Earnings CAGR-
Gross Margin88.5%
Operating Margin8.6%
Net Margin-4.3%
ROE-11.6%
Debt / Equity161.30x
Free Cash Flow$48M
Insider Ownership0.7%
Institutional Ownership104.4%
Short % of Float7.03%
Days to Cover6.4d
1 Week+0.0%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
CAMPBELL BRADLEY LEWISChief Executive OfficerSale22,500$14.35$0.32M2026-03-02
CAMPBELL BRADLEY LEWISChief Executive OfficerSale75,000$14.31$1.07M2026-01-20
CAMPBELL BRADLEY LEWISChief Executive OfficerConversion75,000$6.10$0.46M2026-01-20
CLARK DAVID MICHAELOfficerSale25,642$14.17$0.36M2025-12-19
CAMPBELL BRADLEY LEWISChief Executive OfficerSale77,926$10.86$0.85M2025-12-15
Top Holders
HolderType% HeldValueΔ SharesAs of
Blackrock Inc.institution10.36%$0.47B+25.82%2025-12-31
Vanguard Group Incinstitution9.46%$0.43B+0.57%2025-12-31
HBK Investments L Pinstitution4.86%$0.22B+100.00%2025-12-31
State Street Corporationinstitution4.72%$0.21B+28.28%2025-12-31
Pentwater Capital Management Lpinstitution3.66%$0.17B+100.00%2025-12-31
Bellevue Group AGinstitution3.42%$0.16B+100.00%2025-12-31
William Blair Investment Management, LLCinstitution3.38%$0.15B-32.52%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund3.10%$0.14B+1.89%2025-12-31
Geode Capital Management, LLCinstitution2.34%$0.11B+3.47%2025-12-31
iShares Trust-iShares Russell 2000 ETFfund2.31%$0.11B+2.19%2026-02-28
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fundfund2.23%$0.10B-4.18%2025-12-31
Perceptive Advisors Llcinstitution2.03%$0.09B+0.00%2025-12-31
Goldman Sachs Group Incinstitution1.96%$0.09B+62.33%2025-12-31
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETFfund1.96%$0.09B-25.27%2026-03-31
BlackRock Large Cap Series Fd.s, Inc.-BlackRock Event Driven Eqy. Fd.fund1.94%$0.09B+100.00%2026-02-28
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fundfund1.26%$0.06B-3.31%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund1.06%$0.05B+0.53%2025-12-31
Delaware Group Equity Funds V-Nomura Small Cap Core Fundfund0.93%$0.04B-33.86%2026-02-28
Fidelity Salem Street Trust-Fidelity Small Cap Index Fundfund0.92%$0.04B-1.22%2026-01-31
iShares Trust-iShares Russell 2000 Growth ETFfund0.79%$0.04B-0.64%2026-02-28
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total45
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for FOLD.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.